Skip to main content

All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:

General domain:

Specific domain:

MammaPrint® test for personalised management of adjuvant chemotherapy decisions in early breast cancer

KCE Report 298 (2018) Breast cancer is the most commonly diagnosed cancer in women in Belgium and throughout the world. Provided this cancer is in the early stage, treatment is essentially locoregional, that is, via surgery alone or combined with radiation therapy. In theory, this treatment is enough to eradicate the tumour since it is still limited. However, it is known that about 30% of patients treated in this way are at risk of developing remote metastases, because metastatic cancerous cells are already present but undetectable at the time of diagnosis.

https://kce.fgov.be/en/mammaprint%C2%AE-test-for-personalised-management-of-adjuvant-chemotherapy-decisions-in-early-breast
Economic evaluation of novel direct acting antiviral (DAA) treatment strategies for chronic hepatitis C

KCE Reports 276 (2016)

https://kce.fgov.be/en/economic-evaluation-of-novel-direct-acting-antiviral-daa-treatment-strategies-for-chronic-hepatitis
Future scenarios about drug development and drug pricing

KCE Reports 271 (2016)

https://kce.fgov.be/en/future-scenarios-about-drug-development-and-drug-pricing
Towards a better managed off-label use of drugs

KCE Reports 252 (2015)

https://kce.fgov.be/en/towards-a-better-managed-off-label-use-of-drugs
Towards a guided and phased introduction of high-risk medical devices in Belgium

KCE Reports 249 (2015)

https://kce.fgov.be/en/towards-a-guided-and-phased-introduction-of-high-risk-medical-devices-in-belgium
Publicly funded Practice-oriented Clinical Trials

KCE Reports 246 (2015)

https://kce.fgov.be/en/publicly-funded-practice-oriented-clinical-trials
Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2

KCE Reports 243 (2015)

https://kce.fgov.be/en/oncogenetic-testing-diagnosis-and-follow-up-in-birt-hogg-dub%C3%A9-syndrome-familial-atypical-multiple
Next generation sequencing gene panels for targeted therapy in oncology and haemato-oncology

KCE Reports 240 (2015)

https://kce.fgov.be/en/next-generation-sequencing-gene-panels-for-targeted-therapy-in-oncology-and-haemato-oncology
Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li Fraumeni syndrome and Cowden syndrome

KCE Reports 236 (2015)

https://kce.fgov.be/en/oncogenetic-testing-and-follow-up-for-women-with-familial-breastovarian-cancer-li-fraumeni-syndrome
Hadron therapy in children – an update of the scientific evidence for 15 paediatric cancers

KCE Reports 235 (2015)

https://kce.fgov.be/en/hadron-therapy-in-children-%E2%80%93-an-update-of-the-scientific-evidence-for-15-paediatric-cancers
The non-invasive prenatal test (NIPT) for trisomy 21 – health economic aspects

KCE Reports 222 (2014)

https://kce.fgov.be/en/the-non-invasive-prenatal-test-nipt-for-trisomy-21-%E2%80%93-health-economic-aspects
Non-Small Cell and Small Cell Lung Cancer: Diagnosis, Treatment and Follow-up

KCE Reports 206 (2013)

https://kce.fgov.be/en/non-small-cell-and-small-cell-lung-cancer-diagnosis-treatment-and-follow-up
Extremity-only MRI

KCE Reports 205 (2013)

https://kce.fgov.be/en/extremity-only-mri
Barriers and opportunities for the uptake of biosimilar medicines in Belgium

KCE Reports 199 (2013)

https://kce.fgov.be/en/barriers-and-opportunities-for-the-uptake-of-biosimilar-medicines-in-belgium
Innovative radiotherapy techniques: a multicentre time-driven activity-based costing study

KCE Reports 198 (2013)

https://kce.fgov.be/en/innovative-radiotherapy-techniques-a-multicentre-time-driven-activity-based-costing-study
[Hepatitis C: Screening and Prevention]

KCE Reports 173 (2012)

https://kce.fgov.be/en/hepatitis-c-screening-and-prevention
[Economic evaluation of antiviral treatment of chronic hepatitis B in Belgium]

KCE Reports 157 (2011)

https://kce.fgov.be/en/economic-evaluation-of-antiviral-treatment-of-chronic-hepatitis-b-in-belgium
The pre-market clinical evaluation of innovative high-risk medical devices

KCE Reports 158 (2011)

https://kce.fgov.be/en/the-pre-market-clinical-evaluation-of-innovative-high-risk-medical-devices
Cost-effectiveness of antiviral treatment of chronic hepatitis B in Belgium. Part 1: Literature review and results of a national study

KCE Reports 127 (2010)

https://kce.fgov.be/en/cost-effectiveness-of-antiviral-treatment-of-chronic-hepatitis-b-in-belgium-part-1-literature-review
Pharmaceutical and non-pharmaceutical interventions for Alzheimer’s Disease, a rapid assessment

KCE Reports 111 (2009)

https://kce.fgov.be/en/pharmaceutical-and-non-pharmaceutical-interventions-for-alzheimer%E2%80%99s-disease-a-rapid-assessment